Published in Exp Cell Res on July 15, 2004
WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A (2007) 4.97
BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci U S A (2008) 4.79
Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE). Nat Biotechnol (2008) 3.43
Breast cancer: origins and evolution. J Clin Invest (2007) 3.31
Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer. Breast Cancer Res (2005) 2.43
The protective role of pregnancy in breast cancer. Breast Cancer Res (2005) 1.95
Breast cancer stem cells: tools and models to rely on. BMC Cancer (2009) 1.38
Sox2 promotes tamoxifen resistance in breast cancer cells. EMBO Mol Med (2014) 1.30
Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes. Br J Cancer (2008) 1.27
Senescence evasion by MCF-7 human breast tumor-initiating cells. Breast Cancer Res (2010) 1.19
Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium. PLoS Genet (2011) 1.15
Of microenvironments and mammary stem cells. Stem Cell Rev (2007) 1.14
Breast cancer, side population cells and ABCG2 expression. Cancer Lett (2012) 1.07
Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue. Genes Dev (2011) 1.07
Triple-Negative Breast Cancer: Clinical and Histological Correlations. Breast Care (Basel) (2011) 1.00
Statistical association of basal cell keratins with metastasis-inducing proteins in a prognostically unfavorable group of sporadic breast cancers. Am J Pathol (2011) 0.95
An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells. Breast Cancer Res (2007) 0.94
Unravelling the mystery of stem/progenitor cells in human breast milk. PLoS One (2010) 0.93
An imbalance in progenitor cell populations reflects tumour progression in breast cancer primary culture models. J Exp Clin Cancer Res (2011) 0.91
Breast cancer, stem cells and prospects for therapy. Breast Cancer Res (2006) 0.90
Challenges in the development of future treatments for breast cancer stem cells. Breast Cancer (Dove Med Press) (2010) 0.89
Identification of a cancer stem cell-like side population in the HeLa human cervical carcinoma cell line. Oncol Lett (2013) 0.84
Cancer stem cells and side population cells in breast cancer and metastasis. Cancers (Basel) (2011) 0.84
Distinct effects of EGFR ligands on human mammary epithelial cell differentiation. PLoS One (2013) 0.82
Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model. Breast Cancer Res Treat (2008) 0.81
Mammary stem cell research in veterinary science: an update. Stem Cells Dev (2013) 0.80
The how and why of adult neurogenesis. J Mol Histol (2007) 0.80
ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells. Mol Cancer (2014) 0.80
Mammary development and breast cancer: the role of stem cells. Curr Mol Med (2011) 0.80
Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions. Oncotarget (2015) 0.80
GADD45β Determines Chemoresistance and Invasive Growth of Side Population Cells of Human Embryonic Carcinoma. Stem Cells Int (2010) 0.80
Human Breast Cancer Stem Cells Have Significantly Higher Rate of Clathrin-Independent and Caveolin-Independent Endocytosis than the Differentiated Breast Cancer Cells. J Cancer Sci Ther (2012) 0.77
Human mammospheres secrete hormone-regulated active extracellular vesicles. PLoS One (2014) 0.76
The role of Nanog expression in tamoxifen-resistant breast cancer cells. Onco Targets Ther (2015) 0.76
Breast cancer resistance protein identifies clonogenic keratinocytes in human interfollicular epidermis. Stem Cell Res Ther (2015) 0.75
Dissecting the Biology of Menstrual Cycle-Associated Breast Cancer Risk. Front Oncol (2016) 0.75
The mammary stem cell conundrum: is it unipotent or multipotent? Breast Cancer Res (2012) 0.75
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells. J Vis Exp (2017) 0.75
Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature (2010) 8.48
Single-cell mutational profiling and clonal phylogeny in cancer. Genome Res (2013) 2.10
Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2. Mol Cancer Ther (2011) 1.70
Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of mice. Stem Cells (2005) 1.46
Distinct roles for Wnt-4 and Wnt-11 during retinoic acid-induced neuronal differentiation. Stem Cells (2011) 0.93
High-affinity binding sites for heparin generated on leukocytes during apoptosis arise from nuclear structures segregated during cell death. Blood (2002) 0.89
Global dynamics of two-compartment models for cell production systems with regulatory mechanisms. Math Biosci (2013) 0.79
Dickkopf-3 alters the morphological response to retinoic acid during neuronal differentiation of human embryonal carcinoma cells. Dev Neurobiol (2014) 0.77
Tyrosine kinase inhibitor insensitivity of non-cycling CD34+ human acute myeloid leukaemia cells with FMS-like tyrosine kinase 3 mutations. Br J Haematol (2011) 0.77
Correction: Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling. PLoS Biol (2016) 0.77
Correction: Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling. PLoS Biol (2016) 0.75
Rebuttal: procoagulant activity of T lymphoblastoid cells. Thromb Haemost (2002) 0.75
The impact of long-term lenalidomide exposure on the cellular composition of bone marrow. Leuk Lymphoma (2014) 0.75